Phase II: Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

156 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-09-15

Study Completion Date

2027-09-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This Phase II trial will examine engagement in telehealth for children undergoing psychotherapy. Specifically, the trial will examine patient engagement in Teleo, a virtual therapy platform specifically designed for psychotherapy with youth, as compared to standard video conferencing.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings

NCT06364137

Anxiety Disorders Mood Disorders

COMPLETED NA

Behavioral Telehealth in Low-resource Primary Care Settings for Anxiety and Depression in Youth

NCT06273982

Depression, Anxiety

ENROLLING_BY_INVITATION NA

Targeting Adolescent Depressive Symptoms Via Brief, Web-Based Interventions

NCT04066985

Depression Depressive Disorder Behavioral Symptoms +2 more

UNKNOWN NA

Harnessing Network Science to Personalize Scalable Interventions for Adolescent Depression (TRACK to TREAT Phase 2)

NCT04607902

Depression

UNKNOWN NA

Project 2: Optimizing Engagement and Outcomes in STAND Digital Therapy

NCT05908565

Depression Anxiety

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study aims to examine the impact of tailored telehealth psychotherapy environments on clinical outcomes in the context of pediatric mental health treatment. Researchers will conduct a full-scale RCT with 156 families to assess how Teleo compares to standard video conferencing (e.g., Zoom) on a range of clinical metrics, including cancellation/no-show rates, clinician satisfaction, duration of treatment, need for medication, and symptoms of anxiety and depression.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anxiety Mood Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Teleo

Participants in this arm will undergo therapy for 12 sessions using the Teleo virtual therapy video platform. Sessions will be recorded and questionnaires and clinical data will be measured.

Group Type EXPERIMENTAL

Teleo

Intervention Type OTHER

Therapist-led psychotherapy sessions implemented within the Teleo virtual therapy platform.

Standard Videoconferencing

Participants in this group will undergo therapy for 12 sessions using standard video platforms (e.g. Zoom or Microsoft Teams). Sessions will be recorded and questionnaires and clinical data will be measured.

Group Type ACTIVE_COMPARATOR

Standard Videoconferencing

Intervention Type OTHER

Therapist-led psychotherapy sessions implemented in standard (non-Teleo) video platform.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Teleo

Therapist-led psychotherapy sessions implemented within the Teleo virtual therapy platform.

Intervention Type OTHER

Standard Videoconferencing

Therapist-led psychotherapy sessions implemented in standard (non-Teleo) video platform.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosed with a mood and/or anxiety disorder
* Have proficiency to participate in psychotherapy in English
* Scheduled to begin therapy at one of the study sites
* RCADS score \> 65

Exclusion Criteria

\- Comorbid diagnosis of intellectual disability, autism spectrum disorder, psychotic disorders, high-risk suicidal behaviors requiring immediate hospitalization, substance use disorders, or other physical or mental condition that would prohibit them from engaging in telehealth settings.

Minimum Eligible Age

5 Years

Maximum Eligible Age

14 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No